Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples
Authors:
- Daniel SaarelaDSDaniel Saarela
- Pawel LisPLPawel Lis
- Sara GomesSGSara Gomes
- Raja S. NirujogiRNRaja S. Nirujogi
- Wentao DongWDWentao Dong
- Sophie GlendinningSGSophie Glendinning
- Karolina ZeneviciuteKZKarolina Zeneviciute
- Enrico BagnoliEBEnrico Bagnoli
- Rotimi FasimoyeRFRotimi Fasimoye
- Cindy LinCLCindy Lin
- Kwamina NyameKNKwamina Nyame
Open Access
- 26 December 2024
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (4)
Abstract
Lysosomes are implicated in a wide spectrum of human diseases, including monogenic lysosomal storage disorders (LSDs), age-associated neurodegeneration, and cancer. Profiling lysosomal content using tag-based lysosomal immunoprecipitation (LysoTagIP) in cell and animal models has substantially moved the field forward, but studying lysosomal dysfunction in patients remains challenging. Here, we report the development of the ‘tagless LysoIP’ method, designed to enable the rapid enrichment of lysosomes, via immunoprecipitation, using the endogenous integral lysosomal membrane protein TMEM192, directly from clinical samples and human cell lines (e.g., induced pluripotent stem cell–derived neurons). Isolated lysosomes were intact and suitable for subsequent multimodal omics analyses. To validate our approach, we applied the tagless LysoIP to enrich lysosomes from peripheral blood mononuclear cells derived from fresh blood of healthy donors and patients with CLN3 disease, an autosomal recessive neurodegenerative LSD. Metabolic profiling of isolated lysosomes revealed massive accumulation of glycerophosphodiesters (GPDs) in patients’ lysosomes. Interestingly, a patient with a milder phenotype and genotype displayed lower accumulation of lysosomal GPDs, consistent with their potential role as disease biomarkers. Altogether, the tagless LysoIP provides a framework to study native lysosomes from patient samples, identify disease biomarkers, and discover human-relevant disease mechanisms.Keywords
All Related Versions
Funding Information
- Aligning Science Across Parkinson’s; Chief Scientist Office in Scotland, Wellcome Trust PhD studentship ([ASAO-000463], [SCAF/18/01], [218520/Z/19/Z])
This publication has 40 references indexed in Scilit:
- The Complex Ultrastructure of the Endolysosomal SystemCold Spring Harbor Perspectives in Biology, 2014
- Suspension trapping (STrap) sample preparation method for bottom‐up proteomics analysisProteomics, 2014
- Signals from the lysosome: a control centre for cellular clearance and energy metabolismNature Reviews Molecular Cell Biology, 2013
- New nomenclature and classification scheme for the neuronal ceroid lipofuscinosesNeurology, 2012
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Bicinchoninic acid (BCA) assay in low volumeAnalytical Biochemistry, 2011
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- A clinical rating scale for Batten diseaseNeurology, 2005
- Neuropathic Gaucher's Disease with Normal 4− MethyIumbelliferyl-β-glucosidase Activity in the LiverPediatric Research, 1977